Eli Lilly (LLY)

• Market cap: $967B
• 1 day: 0.53%
• 5 days: 0.31%
• 1 month: 3.27%
• 3 months: 31.78%
• 6 months: 38.64%
• Year to date: 38.85%
• 1 year: 38.85%
• 5 years: 552.79%
• 10 years: 1,203.68%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 47,000